BioAtla, Inc. (BCAB)
NASDAQ·Healthcare·Biotechnology
$4.47
-0.94%
Mkt Cap $5.31M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$5.00
Range $5.00 – $5.00
Implied Upside
+11.9%
Consensus $5.00 vs current $4.47
NASDAQ·Healthcare·Biotechnology
$4.47
-0.94%
Mkt Cap $5.31M
No recent rating data.
Price Target (1 analysts)
$5.00
Range $5.00 – $5.00
+11.9%
Consensus $5.00 vs current $4.47